Aspen Neuroscience to Present at Future of Parkinson's Disease Conference
SAN DIEGO and AUSTIN, Texas, Nov. 30, 2023 /PRNewswire/ -- This week, Aspen Neuroscience will present to the Parkinson's community at the Future of Parkinson's Disease conference, held November 30 – December 3, in Austin.
- SAN DIEGO and AUSTIN, Texas, Nov. 30, 2023 /PRNewswire/ -- This week, Aspen Neuroscience will present to the Parkinson's community at the Future of Parkinson's Disease conference, held November 30 – December 3, in Austin.
- The joint annual conference is hosted by the Parkinson's Foundation and the Parkinson Study Group.
- In addition to multiple scientific presentations, Aspen Chief Executive Officer Damien McDevitt, PhD, and co-founder and Senior Vice President of R&D, Andres Bratt-Leal, PhD, will present updates on company progress for upcoming Phase 1 clinical trials for ANPD001, a personalized (autologous) cell therapy under investigation to treat PD by replacing lost dopamine neurons.
- The Aspen Neuroscience schedule of presentations includes: